Relatlimab, CAS 1673516-98-7

Product Description: Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Thudium K, et, al. Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab. Cancer Immunol Res. 2022 Aug 18:CIR-22-0057.

CAS Number: 1673516-98-7

Molecular Weight: N/A

Compound Purity: 97.78

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: LAG-3

• SKU: MEXHY-P99156-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99156-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK